Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Assura plc ( (GB:AGR) ).
Assura plc announced that several of its key executives have exercised their Performance Share Plan (PSP) awards for 2023 and 2024. The shares were vested and subsequently sold to cover income tax and national insurance liabilities, with the remaining shares sold in full. This move aligns with the company’s remuneration strategy and reflects its commitment to transparency and regulatory compliance, as the transactions were conducted in accordance with the Market Abuse Regulation.
The most recent analyst rating on (GB:AGR) stock is a Buy with a £55.00 price target. To see the full list of analyst forecasts on Assura plc stock, see the GB:AGR Stock Forecast page.
Spark’s Take on GB:AGR Stock
According to Spark, TipRanks’ AI Analyst, GB:AGR is a Outperform.
Assura plc’s strong valuation and positive corporate events are the most significant factors driving the score. Financial performance is robust, though rising debt levels and declining free cash flow growth need monitoring. Technical indicators suggest a neutral market sentiment.
To see Spark’s full report on GB:AGR stock, click here.
More about Assura plc
Assura plc operates in the healthcare real estate sector, specializing in the development and management of primary care properties across the UK. The company focuses on providing high-quality medical facilities, catering primarily to the needs of the National Health Service (NHS) and other healthcare providers.
Average Trading Volume: 23,716,506
Technical Sentiment Signal: Buy
Current Market Cap: £1.61B
Learn more about AGR stock on TipRanks’ Stock Analysis page.